Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
Who we are
January 17, 2024
A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine in Participants With Unresectable or Metastatic Colorectal Cancer
